1,000 patients to report on SI joint implant outcomes in new study
NCT ID NCT06706908
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 1,000 adults who receive an SI-BONE implant for sacroiliac joint pain. Participants fill out online questionnaires about their pain and satisfaction over time. The goal is to see how well the implant works in everyday medical practice.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- iFuse Implant family product
- What this could lead to
- If successful, this study could provide real-world evidence on how well SI-BONE implants reduce pain and improve satisfaction for people with sacroiliac joint dysfunction.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by factors other than the implant. It does not test a new treatment, only tracks outcomes after a standard procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2024
- Expected to finish
-
Dec 2034
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients treated with an implant manufactured by SI-BONE.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age \> 21 at time of screening. 2. Patient will undergo a procedure utilizing an iFuse Implant family product. 3. Patient is comfortable communicating in written and spoken English. 4. Patient is willing and able to complete study questionnaires online, using either a smartphone, tablet, or computer. 5. Patient is willing and able to provide informed consent to participate Exclusion Criteria: 1. Patient has fibromyalgia. 2. Patient has a pain pump. 3. Patient is currently receiving or seeking worker's compensation, disability remuneration, and/or involved in injury litigation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sacroiliac joint dysfunction are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
SI-BONE
Santa Clara, California, 94087, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which Hands-On therapy eases sacroiliac pain better?
- Can cooled radiofrequency beat traditional heat for back pain?
- Can a targeted touch ease stubborn pelvic pain?
- Which exercise works best for sacroiliac pain? a Head-to-Head trial
- New implant offers hope for stubborn back pain sufferers
- Hands-On therapy showdown: which technique eases SI joint pain best?